1. Home
  2. TEVA vs ESS Comparison

TEVA vs ESS Comparison

Compare TEVA & ESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • ESS
  • Stock Information
  • Founded
  • TEVA 1901
  • ESS 1971
  • Country
  • TEVA Israel
  • ESS United States
  • Employees
  • TEVA N/A
  • ESS N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • ESS Real Estate Investment Trusts
  • Sector
  • TEVA Health Care
  • ESS Real Estate
  • Exchange
  • TEVA Nasdaq
  • ESS Nasdaq
  • Market Cap
  • TEVA 18.4B
  • ESS 17.9B
  • IPO Year
  • TEVA N/A
  • ESS 1994
  • Fundamental
  • Price
  • TEVA $16.77
  • ESS $283.91
  • Analyst Decision
  • TEVA Strong Buy
  • ESS Hold
  • Analyst Count
  • TEVA 7
  • ESS 19
  • Target Price
  • TEVA $25.14
  • ESS $310.41
  • AVG Volume (30 Days)
  • TEVA 14.1M
  • ESS 425.8K
  • Earning Date
  • TEVA 05-07-2025
  • ESS 04-29-2025
  • Dividend Yield
  • TEVA N/A
  • ESS 3.62%
  • EPS Growth
  • TEVA N/A
  • ESS 27.78
  • EPS
  • TEVA N/A
  • ESS 10.45
  • Revenue
  • TEVA $16,616,000,000.00
  • ESS $1,861,154,000.00
  • Revenue This Year
  • TEVA $5.69
  • ESS $4.13
  • Revenue Next Year
  • TEVA N/A
  • ESS $3.95
  • P/E Ratio
  • TEVA N/A
  • ESS $27.16
  • Revenue Growth
  • TEVA 3.82
  • ESS 9.74
  • 52 Week Low
  • TEVA $12.47
  • ESS $243.85
  • 52 Week High
  • TEVA $22.80
  • ESS $317.73
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 51.29
  • ESS 52.68
  • Support Level
  • TEVA $16.68
  • ESS $269.10
  • Resistance Level
  • TEVA $18.28
  • ESS $289.12
  • Average True Range (ATR)
  • TEVA 0.63
  • ESS 5.82
  • MACD
  • TEVA -0.04
  • ESS 0.02
  • Stochastic Oscillator
  • TEVA 20.11
  • ESS 73.95

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About ESS Essex Property Trust Inc.

Essex Property Trust owns a portfolio of 256 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.

Share on Social Networks: